Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation.
Mamez AC, Pradier A, Morin S, Giannotti F, Bernardi C, Masouridi-Levrat S, Chalandon Y, Simonetta F. Mamez AC, et al. Among authors: masouridi levrat s. Bone Marrow Transplant. 2024 Nov 15. doi: 10.1038/s41409-024-02458-1. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39548307 No abstract available.
Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis.
Nguyen A, Fender J, Courjon J, Fischer A, Mappoura M, Morin S, Giannotti F, Mamez AC, Chalandon Y, Masouridi-Levrat S, Neofytos D. Nguyen A, et al. Among authors: masouridi levrat s. Transpl Infect Dis. 2024 Dec;26(6):e14375. doi: 10.1111/tid.14375. Epub 2024 Sep 23. Transpl Infect Dis. 2024. PMID: 39312267 Free PMC article.
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study.
Niederwieser D, Hasenclever D, Berdel WE, Biemond BJ, Al-Ali H, Chalandon Y, Van Gelder M, Junghanß C, Gahrton G, Hänel M, Hehlmann R, Heinicke T, Hochhaus A, Iacobelli S, Kooy RVM, Kröger N, Janssen J, Jentzsch M, Breywisch F, Mohty M, Masouridi-Levrat S, Ossenkoppele G, Passweg J, Pönisch W, Schetelig J, Schliemann C, Schwind S, Stelljes M, Verdonck LF, Vucinic V, Löwenberg B, Cornelissen J. Niederwieser D, et al. Among authors: masouridi levrat s. Haematologica. 2025 Jan 1;110(1):68-77. doi: 10.3324/haematol.2024.285879. Haematologica. 2025. PMID: 39113672 Free PMC article. Clinical Trial.
NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivation.
Schäfer A, Calderin Sollet Z, Hervé MP, Buhler S, Ferrari-Lacraz S, Norman PJ, Kichula KM, Farias TDJ, Masouridi-Levrat S, Mamez AC, Pradier A, Simonetta F, Chalandon Y, Villard J. Schäfer A, et al. Among authors: masouridi levrat s. Blood Adv. 2024 Nov 12;8(21):5612-5624. doi: 10.1182/bloodadvances.2024013117. Blood Adv. 2024. PMID: 39047210 Free PMC article.
Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients: a quasi-experimental study.
MacPhail A, Nguyen A, Camus V, Chraïti MN, Dalex E, Chalandon Y, Catho G, Bosetti D, Masouridi-Levrat S, Harbarth S, Zanella MC, Buetti N. MacPhail A, et al. Among authors: masouridi levrat s. J Hosp Infect. 2024 Sep;151:21-28. doi: 10.1016/j.jhin.2024.05.021. Epub 2024 Jun 28. J Hosp Infect. 2024. PMID: 38945400 Free article.
Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D, Baldomero H, Medinger M, Masouridi-Levrat S, Schanz U, Nair G, Güngör T, Halter J, Passweg JR, Chalandon Y; Swiss Stem Cell Transplantation Group (SBST). Heim D, et al. Among authors: masouridi levrat s. Swiss Med Wkly. 2024 May 3;154:3754. doi: 10.57187/s.3754. Swiss Med Wkly. 2024. PMID: 38749067 Free article.
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report.
Giannotti F, De Ramon Ortiz C, Simonetta F, Morin S, Bernardi C, Masouridi-Levrat S, Chalandon Y, Mamez AC. Giannotti F, et al. Among authors: masouridi levrat s. Front Immunol. 2024 Mar 6;15:1360275. doi: 10.3389/fimmu.2024.1360275. eCollection 2024. Front Immunol. 2024. PMID: 38510239 Free PMC article.
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant.
Courjon J, Portillo V, Yerly S, Vetter P, Schibler M, Mappoura M, Morin S, Giannotti F, Mamez AC, van Delden C, Kaiser L, Chalandon Y, Masouridi-Levrat S, Neofytos D. Courjon J, et al. Among authors: masouridi levrat s. Open Forum Infect Dis. 2023 Nov 24;10(12):ofad595. doi: 10.1093/ofid/ofad595. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38094666 Free PMC article.
76 results